British scientific instruments maker Spectris SXS.L has agreed to private equity firm Advent's sweetened takeover offer worth ...

Advent International has outbid KKR in a private equity bidding war for Spectris after the UK industrial group accepted its ...

Advent International said it increased its takeover bid for precision-measurement company Spectris to 4.2 billion pounds ($5.55 billion).

British scientific instruments maker Spectris has agreed to private equity firm Advent's sweetened takeover bid valued at 4.8 billion pounds ($6.38 billion), including debt, the companies said on ...

Precision instrument maker Spectris has agreed to be bought by Advent International after it trumped an offer from US ...

The firm is acting for the Just Group in its £2.4 billion sale, a month after it helped conclude the sale of Spectris to a ...

Advent’s increased offer represents a 2.5 percent increase to the KKR offer. This means the shareholders will receive an additional £1.00 per share, amounting to a total increase of £101.5 million ...

Cognito’s OVERTURE trial demonstrated significant ‘time saved’ in functional and cognitive decline at both six and 18 months.

Cognito Therapeutics Presents Clinical Trial Data Highlighting Neuroprotective Potential of Spectris™ in Alzheimer’s Disease ...

Cognito Therapeutics today announced the presentation of new findings from a study of its non-invasive Spectris neuromodulation system.

Spectris's earnings per share have fallen at approximately 11% a year over the previous five years. When earnings per share fall, the maximum amount of dividends that can be paid also falls.

Spectris PLC Thursday said it has bought Concurrent Real-Time from Battery Ventures for $166.7 million in cash. “The transaction is in line with Spectris’ strategy to make synergistic ...